Check your eligibility References: Astrup, A., Rssner, S., Van Gaal, L., Rissanen, A., Niskanen, L., Al Hakim, M., Madsen, J., Rasmussen, M
Correspondingly, fat mass loss comprised a larger proportion of total weight loss among those who received apitegromab (85.3% of total loss (81.289.5%) or 8.5 kg (7.49.6)) compared to those who received placebo (69.5% (65.773.3%) or 8.0 kg (7.09.0))
Shoulder-to-waist ratio improves
Some appetite changes, sleeping a bit deeper, nothing dramatic
Like other chronic conditions, it requires long-term treatment. GLP-1 Injections Several GLP-1 medications for weight loss are available as injections, including Zepbound, Wegovy and Saxenda
Moreover, meta-analyses and real-world evidence confirm that these benefits extend beyond clinical trials, underscoring their relevance for policymakers and endocrinologists aiming to optimize metabolic disease management